Antihypertensive Medication Class and Functional Outcomes After Nonlobar Intracerebral Hemorrhage

医学 脑出血 内科学 优势比 缬沙坦 血压 队列 逻辑回归 钙通道阻滞剂 队列研究 蛛网膜下腔出血
作者
Mohamed Ridha,James Burke,Padmini Sekar,Daniel Woo,Yousef Hannawi
出处
期刊:JAMA network open [American Medical Association]
卷期号:8 (2): e2457770-e2457770 被引量:1
标识
DOI:10.1001/jamanetworkopen.2024.57770
摘要

Importance Hypertension is the predominant pathology underlying nonlobar intracerebral hemorrhage (ICH), and antihypertensive agents have distinct biological implications for cerebral microvasculature. It is unknown if the class of antihypertensive medications initiated after ICH affects functional outcome beyond blood pressure (BP) control. Objective To ascertain the association between the class of antihypertensive agents initiated during hospitalization and 90-day functional outcome in nonlobar ICH. Design, Setting, and Participants This cohort study uses data from the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study, a case-control cohort study investigating ICH risk factors among Hispanic, non-Hispanic Black (hereafter Black), and non-Hispanic White (hereafter White) populations at 42 US hospitals from 2010 to 2015. Data for this analysis were examined from May to September 2024. ERICH study participants were selected for the present analysis if they survived hospitalization and had available covariate and outcome data. Individuals with complications that would limit antihypertensive choice were excluded. Exposures Initiation of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), calcium channel blocker, β-blocker, thiazide diuretic, and other antihypertensive medications during index hospitalization. Main Outcomes and Measures Primary outcome was a favorable functional outcome, defined as a 90-day (follow-up) modified Rankin Score score of 0 to 2 (score range: 0 [indicating no disability] to 6 [indicating death]). Mixed-effects logistic regression adjusted for demographic characteristics, medical history, ICH characteristics, BP measurement, total number of antihypertensive medications, and hospitalization site was used to calculate the odds of favorable functional outcome. Results Of the 1561 ERICH study participants in the analytic cohort, 1079 had nonlobar and 482 had lobar ICH. Among the 1079 participants in the nonlobar ICH group (mean [SD] age, 58.5 [12.9] years; 676 males [62.6%]; 429 Hispanic [39.8%], 388 Black [36.0%], and 262 White [24.4%] individuals), a total of 407 (37.7%) ACEIs or ARBs, 419 (38.8%) β-blockers, 503 (46.6%) calcium channel blockers, 180 (16.7%) thiazide diuretics, and 277 (25.7%) other antihypertensive classes were initiated during hospitalization (median [IQR], 3 [2-3] agents at discharge). At follow-up, 481 participants (44.6%) had a favorable functional outcome. Initiation of ACEI or ARB was associated with higher odds of favorable functional outcome (adjusted OR [AOR], 1.49; 95% CI, 1.08-2.05; P = .01). No other antihypertensive class was associated with functional outcome. Findings were consistent across several sensitivity analyses. The interaction with ACEI or ARB was mediated by the presence of radiographic features of cerebral small vessel disease (AOR, 3.04; 95% CI, 1.01-9.19; P = .049). No association with class of antihypertensive agent was observed in lobar ICH. Conclusions and Relevance This large cohort study found that initiation of ACEI or ARB was associated with favorable 90-day functional outcomes after nonlobar ICH. This finding supports a medication class–specific benefit in hypertensive arteriopathy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
dengjie完成签到,获得积分10
1秒前
苗条平萱完成签到,获得积分10
1秒前
幼安完成签到,获得积分10
1秒前
利妥昔单抗n完成签到,获得积分10
1秒前
北枳完成签到,获得积分10
2秒前
六六发布了新的文献求助10
2秒前
aiyouwei完成签到,获得积分10
2秒前
大豆大豆不说话完成签到,获得积分10
2秒前
飞鱼完成签到,获得积分10
3秒前
3秒前
4秒前
fx完成签到 ,获得积分10
4秒前
zhutu完成签到,获得积分10
4秒前
潇洒的白昼完成签到,获得积分10
4秒前
xyq完成签到 ,获得积分10
5秒前
windli完成签到,获得积分10
5秒前
roywin完成签到,获得积分10
6秒前
隐形的979发布了新的文献求助10
7秒前
sci完成签到 ,获得积分10
8秒前
Linky完成签到 ,获得积分10
8秒前
cq发布了新的文献求助10
8秒前
凶狠的半山完成签到,获得积分10
8秒前
量子猫完成签到 ,获得积分10
9秒前
Lam完成签到,获得积分10
9秒前
刘威发布了新的文献求助10
10秒前
张三完成签到,获得积分10
10秒前
11秒前
Zephyr完成签到 ,获得积分10
12秒前
875259完成签到,获得积分10
12秒前
12秒前
SciGPT的应助被lancerimpp采纳,获得10
13秒前
Dan完成签到,获得积分10
13秒前
wellforever完成签到 ,获得积分10
14秒前
ma完成签到 ,获得积分10
15秒前
我是老大的应助被小暴采纳,获得10
15秒前
凌凌凌完成签到,获得积分10
16秒前
kongzhiqiqi完成签到,获得积分10
16秒前
yyp完成签到,获得积分10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180111
求助须知:如何正确求助?哪些是违规求助? 9570235
关于积分的说明 21809184
捐赠科研通 7776198
什么是DOI,文献DOI怎么找? 3433262
关于科研通互助平台的介绍 2557463
邀请新用户注册赠送积分活动 2479039